Immunogen reported $239.54M in Cash and Equivalent for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Agios Pharmaceuticals AGIO:US $ 969.12M 918.9M
Amgen AMGN:US $ 6630M 518M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Astellas Pharma 4503:JP Y 301920M 24208M
AstraZeneca AZN:LN 15567M 7931M
Bluebird Bio BLUE:US $ 353.47M 86.25M
Bristol Myers Squibb BMY:US $ 11024M 42M
Cerulean Pharma CERU:US $ 9.11M 1.45M
Dicerna Pharmaceuticals DRNA:US $ 221.21M 62.1M
Eli Lilly And LLY:US $ 3220M 217.6M
Emergent Biosolutions EBS:US $ 447.5M 100.3M
Exelixis EXEL:US $ 492.46M 122.25M
Halozyme Therapeutics HALO:US $ 446.97M 52.48M
Heron Therapeutics HRTX:US $ 191.17M 131.43M
Immunogen IMGN:US $ 239.54M 43.58M
Intrexon XON:US $ 36.41M 9.06M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Macrogenics MGNX:US $ 188.97M 29.53M
Nektar Therapeutics NKTR:US $ 152.34M 2.18M
Novartis NVS:US $ 5117M 1316M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Seattle Genetics SGEN:US $ 413.43M 39.72M